- Zacks via Yahoo FinanceApr 11 13:27 PM
Biotech bigwig Regeneron Pharmaceuticals, Inc. s REGN recently extended collaboration agreement with Alnylam Pharmaceuticals, Inc. ALNY brought ribonucleic acid interference (RNAi) therapeutics in focus.
Biosensors Market Research Report 2019 Global Industry Size, Share, Emerging Growth, Top 10 Players, Demand, Dynamics, Regions, Segments and...Market Watch1 day ago
- Market Watch7 hours ago
Global Hepatitis C Treatment Market 2018 Major Key Players, Trends, Sales, Market Size, Key Developments, Demand, Analysis & Forecast 2023Market Watch2 days ago
The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic AlternativesBenzinga via Yahoo FinanceApr 16 12:10 PM
...: ASMB)(presented interim mid-stage results of its hepatitis B virus treatment candidate ABI-H0731) CELLECT BIOTECH/S ADR (NASDAQ: APOP) Conatus Pharmaceuticals Inc (NASDAQ: CNAT)(announced Phase 2 clinical trial evaluating emricasan in NASH patients with cirrhosis and severe portal hypertension) Fennec Pharmaceuticals Inc (NASDAQ: FENC...
- Zacks via Yahoo FinanceApr 16 14:54 PM
This kit will be used as a companion diagnostic to identify patients eligible for the treatment with Janssen Biotech’s fibroblast growth factor receptor (FGFR) kinase inhibitor drug, ...
- Thomson Reuters StreetEvents via Yahoo FinanceApr 17 16:11 PM
We recently issued our 2018 Janssen U.S. Transparency Report which is now available on our website. We led the industry by publishing this annual report 3 years ago, and we're proud to ...